Meghan Kathleen Bergeron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt UniversityMasters, 2011
Publications & Presentations
PubMed
- 26 citationsCabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation.Amir T. Fathi, Traci M. Blonquist, Daniela Hernandez, Philip C. Amrein, Karen K. Ballen
Cancer. 2018-01-15 - 33 citationsPhase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemiaAmir T. Fathi, Seth A. Wander, Traci M. Blonquist, Andrew M. Brunner, Philip C. Amrein
Haematologica. 2017-04-01
Office
55 Fruit St
Boston, MA 02114Phone+1 617-643-8985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
